These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17927722)

  • 1. Metabolism of a highly selective gelatinase inhibitor generates active metabolite.
    Lee M; Villegas-Estrada A; Celenza G; Boggess B; Toth M; Kreitinger G; Forbes C; Fridman R; Mobashery S; Chang M
    Chem Biol Drug Des; 2007 Nov; 70(5):371-82. PubMed ID: 17927722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors.
    Lee M; Bernardo MM; Meroueh SO; Brown S; Fridman R; Mobashery S
    Org Lett; 2005 Sep; 7(20):4463-5. PubMed ID: 16178559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples.
    Hesek D; Toth M; Meroueh SO; Brown S; Zhao H; Sakr W; Fridman R; Mobashery S
    Chem Biol; 2006 Apr; 13(4):379-86. PubMed ID: 16632250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
    Grams F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi V; Menta E; Oliva A; Zimmermann G; Gram F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi VMenta E; Oliva A; Zimmermann G
    Biol Chem; 2001 Aug; 382(8):1277-85. PubMed ID: 11592410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
    Krüger A; Arlt MJ; Gerg M; Kopitz C; Bernardo MM; Chang M; Mobashery S; Fridman R
    Cancer Res; 2005 May; 65(9):3523-6. PubMed ID: 15867341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-substituted homopiperazine barbiturates as gelatinase inhibitors.
    Wang J; Medina C; Radomski MW; Gilmer JF
    Bioorg Med Chem; 2011 Aug; 19(16):4985-99. PubMed ID: 21764590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.
    Tamura Y; Watanabe F; Nakatani T; Yasui K; Fuji M; Komurasaki T; Tsuzuki H; Maekawa R; Yoshioka T; Kawada K; Sugita K; Ohtani M
    J Med Chem; 1998 Feb; 41(4):640-9. PubMed ID: 9484512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.
    Moroy G; Denhez C; El Mourabit H; Toribio A; Dassonville A; Decarme M; Renault JH; Mirand C; Bellon G; Sapi J; Alix AJ; Hornebeck W; Bourguet E
    Bioorg Med Chem; 2007 Jul; 15(14):4753-66. PubMed ID: 17512742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
    Chen MH; Cui SX; Cheng YN; Sun LR; Li QB; Xu WF; Ward SG; Tang W; Qu XJ
    Anticancer Drugs; 2008 Nov; 19(10):957-65. PubMed ID: 18827560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.
    Yang SM; Scannevin RH; Wang B; Burke SL; Wilson LJ; Karnachi P; Rhodes KJ; Lagu B; Murray WV
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1135-9. PubMed ID: 18086526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase inhibitors: a structure-activity study.
    Levy DE; Lapierre F; Liang W; Ye W; Lange CW; Li X; Grobelny D; Casabonne M; Tyrrell D; Holme K; Nadzan A; Galardy RE
    J Med Chem; 1998 Jan; 41(2):199-223. PubMed ID: 9457244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.
    Zhang YM; Fan X; Chakaravarty D; Xiang B; Scannevin RH; Huang Z; Ma J; Burke SL; Karnachi P; Rhodes KJ; Jackson PF
    Bioorg Med Chem Lett; 2008 Jan; 18(1):409-13. PubMed ID: 17981034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and structure determination of gelatinase and collagenase inhibitors from Viola patrinii fermentation extracts.
    Kim KS; Kwak YJ; Kim KM; Yu HY; Kang BW; Chung E; Lee YC; Kim JI; Lee JH
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):614-6. PubMed ID: 20196628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.
    Yang SM; Scannevin RH; Wang B; Burke SL; Huang Z; Karnachi P; Wilson LJ; Rhodes KJ; Lagu B; Murray WV
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1140-5. PubMed ID: 18083558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines.
    Szardenings AK; Antonenko V; Campbell DA; DeFrancisco N; Ida S; Shi L; Sharkov N; Tien D; Wang Y; Navre M
    J Med Chem; 1999 Apr; 42(8):1348-57. PubMed ID: 10212120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.
    Tuccinardi T; Martinelli A; Nuti E; Carelli P; Balzano F; Uccello-Barretta G; Murphy G; Rossello A
    Bioorg Med Chem; 2006 Jun; 14(12):4260-76. PubMed ID: 16483784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.
    Topai A; Breccia P; Minissi F; Padova A; Marini S; Cerbara I
    Bioorg Med Chem; 2012 Apr; 20(7):2323-37. PubMed ID: 22386984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.